We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Alliance Pharma Plc | LSE:APH | London | Ordinary Share | GB0031030819 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.30 | -0.88% | 33.70 | 33.70 | 33.85 | 34.30 | 33.45 | 34.30 | 811,749 | 16:35:09 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 167.42M | 936k | 0.0017 | 199.12 | 182.84M |
TIDMAPH
RNS Number : 1791Z
Alliance Pharma PLC
19 May 2021
For immediate release 19 May 2021
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
Result of AGM
Alliance Pharma plc (AIM: APH), the international healthcare group, announces that, at its Annual General Meeting held earlier today, all the resolutions, as set out in the Notice of Meeting, were duly passed on a poll.
The votes were as follows:
RESOLUTION VOTES % VOTES % VOTES % OF VOTES WITHHELD FOR AGAINST TOTAL ISC VOTED ============================== ============ ======= =========== ====== ============ =========== =============== 1 Report and Accounts 370,082,283 99.99 2,000 0.01 370,084,283 69.20 365,173 2 Final dividend 370,448,446 100.00 0 0.00 370,448,446 69.27 1,010 3 Re-elect D. Cook 364,919,306 98.52 5,491,119 1.48 370,410,425 69.26 39,031 4 Re-elect P. Butterfield 369,183,937 99.67 1,229,509 0.33 370,413,446 69.26 36,010 5 Re-elect A. Franklin 368,811,050 99.57 1,602,396 0.43 370,413,446 69.26 36,010 6 Re-elect J. LeCouilliard 369,062,346 99.64 1,351,100 0.36 370,413,446 69.26 36,010 7 Re-elect R. Jones 369,069,846 99.64 1,340,579 0.36 370,410,425 69.26 39,031 8 Re-appoint Auditor 370,335,621 99.98 82,835 0.02 370,418,456 69.26 31,000 Remuneration 9 of Auditor 370,375,357 99.99 43,099 0.01 370,418,456 69.26 31,00 10 Allot shares 322,454,915 87.05 47,976,358 12.95 370,431,273 69.26 18,183 Disapply Pre-emption 11 rights 310,764,742 83.89 59,666,531 16.11 370,431,273 69.26 18,183
The number of the Group's shares in issue as at the date of the meeting was 534,827,034 ordinary shares of 1p each.
Please note that each share carries one vote and that a 'vote withheld' is not a vote in law and has not been counted in the calculation of the proportion of the votes for and against the resolution. Any proxy appointments which gave discretion to the Chairman have been included in the 'votes for' total.
Chris Chrysanthou
Head of Legal & Company Secretary
19 May 2021
For further information:
Alliance Pharma plc + 44 (0)1249 466966 Peter Butterfield, Chief Executive Officer Andrew Franklin, Chief Financial Officer www.alliancepharma.co.uk Buchanan + 44 (0)20 7466 5000 Mark Court / Sophie Wills / Hannah Ratcliff Numis Securities Limited + 44 (0)20 7260 1000 Nominated Adviser: Freddie Barnfield / Oliver Steele Corporate Broking: James Black Investec Bank plc + 44 (0) 20 7597 5970 Corporate Finance: Daniel Adams Corporate Broking: Patrick Robb
About Alliance
Alliance Pharma plc (AIM: APH) is an international healthcare group, headquartered in the UK with subsidiaries in Europe, the Far East and the US and wide international reach through an extensive network of distributors, generating sales in more than 100 countries.
We hold the marketing rights to around 80 Consumer Healthcare brands and Prescription Medicines, which are managed on a portfolio basis according to their growth potential. Promotional investment is focused primarily on our Consumer healthcare brands, many of which have significant international or multi-territory reach. Our Prescription Medicines are generally sold in a more limited number of local markets, and most require little or no promotional investment.
Our strategy allows us to deliver good organic growth and to enhance our growth rate through carefully selected acquisitions.
For more information on Alliance, please visit our website : www.alliancepharmaceuticals.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RAGDKCBPBBKDQPD
(END) Dow Jones Newswires
May 19, 2021 08:56 ET (12:56 GMT)
1 Year Alliance Pharma Chart |
1 Month Alliance Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions